Outcomes after percutaneous coronary interventions in patients with chronic kidney disease

Chronic kidney disease (CKD) is a significant contributor to cardiovascular morbidity and mortality. Patients with CKD are known to have a greater prevalence of cardiovascular disease than the general population,1 and patients with concurrent CKD and coronary artery disease (CAD) have greater mortality than patients without CKD.2 4 The rate of cardiovascular mortality is approximately 50%, five to 10 times higher than the general population.